These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26075436)

  • 1. Clonal diversity in glioblastoma: is it clinically relevant?
    Watts C; Piccirillo SG
    Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics illuminates a deadly brain cancer.
    Kuehn BM
    JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
    Parsa AT
    World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
    [No Abstract]   [Full Text] [Related]  

  • 4. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SnapShot: glioblastoma multiforme.
    Kotliarova S; Fine HA
    Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of therapeutic targets for glioblastoma by network analysis.
    Friedmann-Morvinski D; Bhargava V; Gupta S; Verma IM; Subramaniam S
    Oncogene; 2016 Feb; 35(5):608-20. PubMed ID: 25961929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets in glioblastoma.
    Zorzan M; Giordan E; Redaelli M; Caretta A; Mucignat-Caretta C
    Future Oncol; 2015; 11(9):1407-20. PubMed ID: 25952786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [System biological approach to research and treatment of brain tumors].
    Shiraishi T; Tabuchi K; Kotani S; Konagaya A
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(7):795-801. PubMed ID: 12795192
    [No Abstract]   [Full Text] [Related]  

  • 11. Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.
    Fatoo A; Nanaszko MJ; Allen BB; Mok CL; Bukanova EN; Beyene R; Moliterno JA; Boockvar JA
    J Neurooncol; 2011 Jul; 103(3):397-408. PubMed ID: 20853017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
    Mahlokozera T; Vellimana AK; Li T; Mao DD; Zohny ZS; Kim DH; Tran DD; Marcus DS; Fouke SJ; Campian JL; Dunn GP; Miller CA; Kim AH
    Neuro Oncol; 2018 Mar; 20(4):472-483. PubMed ID: 29244145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive adult primary glioblastoma in the medulla oblongata with an unmethylated MGMT promoter and without an IDH mutation.
    Yoshikawa A; Nakada M; Watanabe T; Hayashi Y; Sabit H; Kato Y; Suzuki S; Ooi A; Sato H; Hamada J
    Brain Tumor Pathol; 2013 Jul; 30(3):175-9. PubMed ID: 23053494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Genomics of Glioblastoma: Biology, Biomarkers, and Breakthroughs.
    Moton S; Elbanan M; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2015 Jun; 24(3):155-63. PubMed ID: 26049819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation.
    Gursel DB; Schlaff CD; Boockvar JA
    Neurosurgery; 2012 Oct; 71(4):N17-8. PubMed ID: 22989968
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
    Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
    Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.